Literature DB >> 25965847

Upper extremity 3-dimensional reachable workspace assessment in amyotrophic lateral sclerosis by Kinect sensor.

Bjorn Oskarsson1, Nanette C Joyce2, Evan De Bie2, Alina Nicorici2, Ruzena Bajcsy3, Gregorij Kurillo3, Jay J Han2.   

Abstract

INTRODUCTION: Reachable workspace is a measure that provides clinically meaningful information regarding arm function. In this study, a Kinect sensor was used to determine the spectrum of 3-dimensional reachable workspace encountered in a cross-sectional cohort of individuals with amyotrophic lateral sclerosis (ALS).
METHODS: Bilateral 3D reachable workspace was recorded from 10 subjects with ALS and 17 healthy controls. The data were normalized by each individual's arm length to obtain a reachable workspace relative surface area (RSA). Concurrent validity was assessed by correlation with scoring on the ALS Functional Rating Score-revised (ALSFRSr).
RESULTS: The Kinect-measured reachable workspace RSA differed significantly between the ALS and control subjects (0.579 ± 0.226 vs. 0.786 ± 0.069; P < 0.001). The RSA demonstrated correlation with ALSFRSr upper extremity items (Spearman correlation ρ = 0.569; P = 0.009). With worsening upper extremity function, as categorized by the ALSFRSr, the reachable workspace also decreased progressively.
CONCLUSIONS: This study demonstrates the feasibility and potential of using a novel Kinect-based reachable workspace outcome measure in ALS.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ALS; Kinect; outcome measure; reachable workspace; upper extremity

Mesh:

Year:  2015        PMID: 25965847      PMCID: PMC4770889          DOI: 10.1002/mus.24703

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  14 in total

1.  Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials.

Authors:  Patricia L Andres; Linda M Skerry; Theodore L Munsat; Brenda J Thornell; Jackie Szymonifka; David A Schoenfeld; Merit E Cudkowicz
Journal:  Muscle Nerve       Date:  2012-01       Impact factor: 3.217

2.  A study to evaluate safety and tolerability of repeated doses of tirasemtiv in patients with amyotrophic lateral sclerosis.

Authors:  Jeremy M Shefner; Mary Lou Watson; Lisa Meng; Andrew A Wolff
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-08-19       Impact factor: 4.092

3.  Evaluation of upper extremity reachable workspace using Kinect camera.

Authors:  Gregorij Kurillo; Alic Chen; Ruzena Bajcsy; Jay J Han
Journal:  Technol Health Care       Date:  2013       Impact factor: 1.285

4.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

5.  Clinical trial in Duchenne dystrophy. I. The design of the protocol.

Authors:  M H Brooke; R C Griggs; J R Mendell; G M Fenichel; J B Shumate; R J Pellegrino
Journal:  Muscle Nerve       Date:  1981 May-Jun       Impact factor: 3.217

Review 6.  State of play in amyotrophic lateral sclerosis genetics.

Authors:  Alan E Renton; Adriano Chiò; Bryan J Traynor
Journal:  Nat Neurosci       Date:  2013-12-26       Impact factor: 24.884

Review 7.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

8.  Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis.

Authors:  Franco Franchignoni; Gabriele Mora; Andrea Giordano; Paolo Volanti; Adriano Chiò
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-20       Impact factor: 10.154

9.  Development and application of stereo camera-based upper extremity workspace evaluation in patients with neuromuscular diseases.

Authors:  Gregorij Kurillo; Jay J Han; Richard T Abresch; Alina Nicorici; Posu Yan; Ruzena Bajcsy
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

10.  Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.

Authors:  Eva L Feldman; Nicholas M Boulis; Junguk Hur; Karl Johe; Seward B Rutkove; Thais Federici; Meraida Polak; Jane Bordeau; Stacey A Sakowski; Jonathan D Glass
Journal:  Ann Neurol       Date:  2014-03-07       Impact factor: 10.422

View more
  5 in total

1.  An Objective Functional Characterisation of Head Movement Impairment in Individuals with Neck Muscle Weakness Due to Amyotrophic Lateral Sclerosis.

Authors:  Silvia Pancani; Wendy Tindale; Pamela J Shaw; Christopher J McDermott; Claudia Mazzà
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

Review 2.  Measurement of upper limb function in ALS: a structured review of current methods and future directions.

Authors:  C D Hayden; B P Murphy; O Hardiman; D Murray
Journal:  J Neurol       Date:  2022-05-25       Impact factor: 6.682

3.  Evaluating surface EMG control of motorized wheelchairs for amyotrophic lateral sclerosis patients.

Authors:  Albert C Manero; Shea L McLinden; John Sparkman; Björn Oskarsson
Journal:  J Neuroeng Rehabil       Date:  2022-08-14       Impact factor: 5.208

Review 4.  A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease.

Authors:  Emily Beswick; Thomas Fawcett; Zack Hassan; Deborah Forbes; Rachel Dakin; Judith Newton; Sharon Abrahams; Alan Carson; Siddharthan Chandran; David Perry; Suvankar Pal
Journal:  J Neurol       Date:  2022-08-09       Impact factor: 6.682

5.  Reachable workspace analysis is a potential measurement for impairment of the upper extremity in neuralgic amyotrophy.

Authors:  Jos IJspeert; Renee Lustenhouwer; Renske M Janssen; Jay J Han; Maya N Hatch; Ian Cameron; Rick C Helmich; Baziel van Engelen; Philip van der Wees; Alexander C H Geurts; Nens van Alfen; Jan T Groothuis
Journal:  Muscle Nerve       Date:  2022-06-21       Impact factor: 3.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.